Polycystic ovary syndrome (PCOS) disrupts hormone regulation and insulin signaling in approximately 813% of reproductive-age women worldwide
Studies using the mouse Glp1r promoter to drive expression of a fluorescent reporter protein reveal Glp1r expression in the antral area of the stomach (near the gastric pylorus) as a fibrous signal that does not overlap with smooth muscle -actin (SMA) (Richards et al., 2014)
Prez-Barbosa L, Esquivel-Valerio JA, Arana-Guajardo AC et al (2015) Increased detection of latent tuberculosis by tuberculin skin test and booster phenomenon in early rheumatoid arthritis patients
Excessive straining can further irritate the cervix
So, that's where semaglutide would come into play
What the evidence actually suggests The strongest clinical evidence supports the idea that GLP-1 medications can improve inflammatory markers in many patients, particularly those with obesity, type 2 diabetes, fatty liver disease, and cardiovascular risk